| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.724 | 0.027 | 0.874 | Antiinflammatory | 0.874 0.007 CID_154699944 | CID_154699944 | |
| 0.664 | 0.037 | 0.84 | Apoptosis agonist | 0.84 0.012 CID_154699944 | CID_154699944 | |
| 0.622 | 0.005 | 0.622 | GABA C receptor rho-3 antagonist | |||
| 0.618 | 0.002 | 0.618 | Succinate dehydrogenase inhibitor | 0.197 0.051 CID_154699944 | ||
| 0.608 | 0.018 | 0.734 | Cholesterol antagonist | 0.734 0.006 CID_154699944 | CID_154699944 | |
| 0.591 | 0.004 | 0.591 | Phospholipase C inhibitor | 0.395 0.011 CID_154699944 | ||
| 0.542 | 0.023 | 0.739 | Antithrombotic | 0.739 0.006 CID_154699944 | CID_154699944 | |
| 0.526 | 0.01 | 0.526 | Hypolipemic | 0.478 0.014 CID_154699944 | ||
| 0.536 | 0.024 | 0.626 | Immunosuppressant | 0.626 0.01 CID_154699944 | CID_154699944 | |
| 0.525 | 0.021 | 0.591 | Histamine release inhibitor | 0.591 0.011 CID_154699944 | CID_154699944 | |
| 0.498 | 0.02 | 0.745 | Antioxidant | 0.745 0.005 CID_154699944 | CID_154699944 | |
| 0.519 | 0.053 | 0.757 | Caspase 9 stimulant | 0.757 0.017 CID_154699944 | CID_154699944 | |
| 0.475 | 0.018 | 0.703 | Hypoglycemic | 0.703 0.005 CID_154699944 | CID_154699944 | |
| 0.474 | 0.032 | 0.486 | 5 Hydroxytryptamine release stimulant | 0.486 0.03 CID_154699944 | CID_154699944 | |
| 0.486 | 0.045 | 0.72 | Antibacterial | 0.72 0.007 CID_154699944 | CID_154699944 | |
| 0.44 | 0.003 | 0.44 | Ferrochelatase inhibitor | |||
| 0.456 | 0.021 | 0.663 | Free radical scavenger | 0.663 0.006 CID_154699944 | CID_154699944 | |
| 0.446 | 0.019 | 0.446 | Superoxide dismutase inhibitor | |||
| 0.479 | 0.057 | 0.755 | Cyclophilin D inhibitor | 0.755 0.009 CID_154699944 | CID_154699944 | |
| 0.428 | 0.008 | 0.505 | Alpha-N-acetylglucosaminidase inhibitor | 0.505 0.005 CID_154699944 | CID_154699944 | |
| 0.408 | 0.013 | 0.408 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.398 | 0.005 | 0.398 | GABA C receptor agonist | |||
| 0.421 | 0.032 | 0.421 | Lipoxygenase inhibitor | |||
| 0.409 | 0.022 | 0.548 | Vasodilator | 0.548 0.009 CID_154699944 | CID_154699944 | |
| 0.388 | 0.018 | 0.4 | Anesthetic general | 0.4 0.016 CID_154699944 | CID_154699944 | |
| 0.424 | 0.058 | 0.812 | Transcription factor NF kappa B inhibitor | 0.812 0.012 CID_154699944 | CID_154699944 | |
| 0.371 | 0.014 | 0.429 | Thrombolytic | 0.429 0.009 CID_154699944 | CID_154699944 | |
| 0.367 | 0.013 | 0.367 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.405 | 0.054 | 0.408 | Vasodilator, peripheral | 0.408 0.053 CID_154699944 | CID_154699944 | |
| 0.397 | 0.047 | 0.397 | Aldehyde oxidase inhibitor | |||
| 0.346 | 0.004 | 0.346 | Farnesoid X receptor antagonist | 0.164 0.039 CID_154699944 | ||
| 0.344 | 0.004 | 0.4 | Phosphofructokinase-1 inhibitor | 0.4 0.003 CID_154699944 | CID_154699944 | |
| 0.389 | 0.053 | 0.657 | Immunostimulant | 0.657 0.011 CID_154699944 | CID_154699944 | |
| 0.34 | 0.004 | 0.34 | Beta tubulin antagonist | |||
| 0.337 | 0.004 | 0.337 | GABA C receptor antagonist | |||
| 0.375 | 0.046 | 0.478 | Apoptosis antagonist | 0.478 0.023 CID_154699944 | CID_154699944 | |
| 0.379 | 0.051 | 0.379 | Caspase 3 stimulant | 0.377 0.051 CID_154699944 | ||
| 0.331 | 0.01 | 0.331 | Phospholipase A2 inhibitor | 0.254 0.022 CID_154699944 | ||
| 0.314 | 0.006 | 0.314 | Adenylate kinase inhibitor | 0.194 0.016 CID_154699944 | ||
| 0.336 | 0.034 | 0.632 | Nitric oxide antagonist | 0.632 0.008 CID_154699944 | CID_154699944 | |
| 0.384 | 0.088 | 0.384 | 5 Hydroxytryptamine release inhibitor | 0.337 0.127 CID_154699944 | ||
| 0.289 | 0.003 | 0.289 | Ca(v)3.1 blocker | 0.085 0.046 CID_154699944 | ||
| 0.301 | 0.019 | 0.301 | Protein-tyrosine phosphatase inhibitor | 0.222 0.039 CID_154699944 | ||
| 0.301 | 0.019 | 0.301 | Tubulin antagonist | |||
| 0.308 | 0.028 | 0.308 | Gastrin inhibitor | 0.229 0.106 CID_154699944 | ||
| 0.317 | 0.04 | 0.317 | Antimitotic | 0.16 0.112 CID_154699944 | ||
| 0.292 | 0.019 | 0.451 | Amylase inhibitor | 0.451 0.007 CID_154699944 | CID_154699944 | |
| 0.279 | 0.006 | 0.279 | Porphobilinogen synthase inhibitor | |||
| 0.285 | 0.013 | 0.285 | Cholesterol synthesis inhibitor | 0.157 0.041 CID_154699944 | ||
| 0.273 | 0.004 | 0.273 | GABA C receptor rho-1 antagonist | |||
| 0.276 | 0.008 | 0.276 | GABA C receptor rho-2 antagonist | |||
| 0.325 | 0.058 | 0.325 | Sodium/bile acid cotransporter inhibitor | |||
| 0.285 | 0.019 | 0.285 | Insulin sensitizer | 0.188 0.086 CID_154699944 | ||
| 0.265 | 0.001 | 0.265 | Kainate receptor agonist | 0.065 0.005 CID_154699944 | ||
| 0.273 | 0.013 | 0.273 | Protein-tyrosine phosphatase 1B inhibitor | 0.224 0.023 CID_154699944 | ||
| 0.273 | 0.015 | 0.273 | Aldehyde dehydrogenase inhibitor | 0.174 0.036 CID_154699944 | ||
| 0.287 | 0.033 | 0.543 | Hepatoprotectant | 0.543 0.005 CID_154699944 | CID_154699944 | |
| 0.258 | 0.004 | 0.258 | Arachidonic acid antagonist | 0.214 0.021 CID_154699944 | ||
| 0.275 | 0.026 | 0.275 | Neurotrophic factor enhancer | 0.249 0.039 CID_154699944 | ||
| 0.257 | 0.014 | 0.384 | Cell adhesion inhibitor | 0.384 0.005 CID_154699944 | CID_154699944 | |
| 0.247 | 0.004 | 0.247 | CDC25B inhibitor | 0.108 0.014 CID_154699944 | ||
| 0.248 | 0.007 | 0.338 | Triose-phosphate isomerase inhibitor | 0.338 0.004 CID_154699944 | CID_154699944 | |
| 0.247 | 0.009 | 0.264 | Microtubule formation inhibitor | 0.264 0.005 CID_154699944 | CID_154699944 | |
| 0.24 | 0.004 | 0.24 | GABA aminotransferase inhibitor | 0.164 0.006 CID_154699944 | ||
| 0.261 | 0.026 | 0.402 | Interferon gamma antagonist | 0.402 0.011 CID_154699944 | CID_154699944 | |
| 0.304 | 0.071 | 0.497 | Interleukin 2 agonist | 0.497 0.008 CID_154699944 | CID_154699944 | |
| 0.258 | 0.027 | 0.371 | Melanin inhibitor | 0.371 0.014 CID_154699944 | CID_154699944 | |
| 0.234 | 0.005 | 0.234 | Glutamate decarboxylase inhibitor | |||
| 0.229 | 0.008 | 0.257 | Photosensitizer | 0.257 0.005 CID_154699944 | CID_154699944 | |
| 0.227 | 0.007 | 0.227 | TRPA1 agonist | 0.127 0.051 CID_154699944 | ||
| 0.222 | 0.003 | 0.222 | Aconitate hydratase inhibitor | |||
| 0.22 | 0.007 | 0.22 | Adenylate cyclase stimulant | 0.174 0.031 CID_154699944 | ||
| 0.257 | 0.046 | 0.396 | Peptidyltransferase inhibitor | 0.396 0.007 CID_154699944 | CID_154699944 | |
| 0.215 | 0.004 | 0.215 | Kainate receptor antagonist | |||
| 0.28 | 0.071 | 0.28 | Insulysin inhibitor | |||
| 0.215 | 0.009 | 0.215 | Glutamate dehydrogenase inhibitor | 0.105 0.028 CID_154699944 | ||
| 0.208 | 0.005 | 0.208 | Acyl-CoA dehydrogenase inhibitor | 0.095 0.017 CID_154699944 | ||
| 0.208 | 0.005 | 0.208 | Toll-Like receptor 4 antagonist | 0.194 0.007 CID_154699944 | ||
| 0.209 | 0.007 | 0.209 | Electrolyte absorption antagonist | |||
| 0.261 | 0.06 | 0.441 | DNA synthesis inhibitor | 0.441 0.018 CID_154699944 | CID_154699944 | |
| 0.293 | 0.093 | 0.465 | Vasodilator, coronary | 0.465 0.021 CID_154699944 | CID_154699944 | |
| 0.222 | 0.026 | 0.222 | Insulin secretagoues | 0.221 0.027 CID_154699944 | ||
| 0.219 | 0.023 | 0.405 | Cell wall synthesis inhibitor | 0.405 0.006 CID_154699944 | CID_154699944 | |
| 0.201 | 0.008 | 0.201 | Electron transport complex I inhibitor | 0.109 0.063 CID_154699944 | ||
| 0.222 | 0.03 | 0.222 | Interleukin 6 antagonist | 0.158 0.078 CID_154699944 | ||
| 0.283 | 0.092 | 0.55 | Immunomodulator | 0.55 0.017 CID_154699944 | CID_154699944 | |
| 0.312 | 0.124 | 0.312 | 15-Lipoxygenase inhibitor | |||
| 0.24 | 0.051 | 0.24 | DNA methyltransferase I inhibitor | 0.201 0.069 CID_154699944 | ||
| 0.195 | 0.007 | 0.195 | Ornithine carbamoyltransferase inhibitor | 0.08 0.021 CID_154699944 | ||
| 0.21 | 0.025 | 0.245 | DNA polymerase I inhibitor | 0.245 0.018 CID_154699944 | CID_154699944 | |
| 0.189 | 0.004 | 0.212 | Ca2+-transporting ATPase inhibitor | 0.212 0.003 CID_154699944 | CID_154699944 | |
| 0.206 | 0.021 | 0.206 | Toll-Like receptor 2 antagonist | |||
| 0.2 | 0.016 | 0.243 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.243 0.01 CID_154699944 | CID_154699944 | |
| 0.19 | 0.007 | 0.19 | Alcohol oxidase inhibitor | |||
| 0.188 | 0.006 | 0.188 | Glutathione S-transferase inhibitor | |||
| 0.186 | 0.006 | 0.186 | Biliverdin reductase inhibitor | 0.079 0.027 CID_154699944 | ||
| 0.186 | 0.008 | 0.186 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.214 | 0.037 | 0.336 | Protein kinase stimulant | 0.336 0.013 CID_154699944 | CID_154699944 | |
| 0.182 | 0.005 | 0.182 | Glycine receptor agonist | 0.15 0.007 CID_154699944 | ||
| 0.229 | 0.052 | 0.229 | Peroxidase inhibitor | |||
| 0.253 | 0.076 | 0.37 | Interleukin agonist | 0.37 0.024 CID_154699944 | CID_154699944 | |
| 0.187 | 0.011 | 0.187 | Prolactin inhibitor | |||
| 0.179 | 0.003 | 0.179 | Fumarate hydratase inhibitor | 0.048 0.014 CID_154699944 | ||
| 0.219 | 0.052 | 0.219 | Growth hormone agonist | |||
| 0.185 | 0.018 | 0.185 | Catalase inhibitor | |||
| 0.169 | 0.003 | 0.169 | Kainate receptor 1 antagonist | |||
| 0.166 | 0.003 | 0.166 | Retinoid X beta receptor agonist | 0.028 0.009 CID_154699944 | ||
| 0.17 | 0.007 | 0.17 | Ornithine decarboxylase inhibitor | 0.108 0.036 CID_154699944 | ||
| 0.18 | 0.018 | 0.18 | Vanilloid 1 agonist | 0.162 0.028 CID_154699944 | ||
| 0.183 | 0.024 | 0.342 | Antineoplastic antibiotic | 0.342 0.007 CID_154699944 | CID_154699944 | |
| 0.169 | 0.014 | 0.169 | ABCA1 expression enhancer | |||
| 0.172 | 0.019 | 0.172 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.156 | 0.003 | 0.156 | Kainate receptor 2 antagonist | |||
| 0.162 | 0.01 | 0.162 | Argininosuccinate synthase inhibitor | 0.066 0.032 CID_154699944 | ||
| 0.179 | 0.029 | 0.179 | 5-Lipoxygenase inhibitor | |||
| 0.193 | 0.045 | 0.43 | Lipid peroxidase inhibitor | 0.43 0.008 CID_154699944 | CID_154699944 | |
| 0.176 | 0.029 | 0.286 | Cyclooxygenase 3 inhibitor | 0.286 0.006 CID_154699944 | CID_154699944 | |
| 0.149 | 0.004 | 0.149 | Squalene synthetase inhibitor | 0.131 0.004 CID_154699944 | ||
| 0.164 | 0.019 | 0.164 | Creatine kinase inhibitor | |||
| 0.152 | 0.007 | 0.183 | Glycine receptor antagonist | 0.183 0.004 CID_154699944 | CID_154699944 | |
| 0.165 | 0.02 | 0.165 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.158 | 0.014 | 0.158 | Anabolic | 0.111 0.048 CID_154699944 | ||
| 0.139 | 0.004 | 0.139 | Kainate receptor 5 antagonist | |||
| 0.208 | 0.074 | 0.237 | DNA methylase inhibitor | 0.237 0.056 CID_154699944 | CID_154699944 | |
| 0.185 | 0.052 | 0.294 | ATPase inhibitor | 0.294 0.007 CID_154699944 | CID_154699944 | |
| 0.135 | 0.003 | 0.135 | Retinoid X gamma receptor agonist | 0.033 0.009 CID_154699944 | ||
| 0.141 | 0.011 | 0.141 | Leukotriene antagonist | 0.103 0.02 CID_154699944 | ||
| 0.162 | 0.033 | 0.162 | Aminopeptidase B inhibitor | |||
| 0.129 | 0.005 | 0.129 | AMPA 2 receptor antagonist | |||
| 0.215 | 0.091 | 0.307 | Platelet antagonist | 0.307 0.051 CID_154699944 | CID_154699944 | |
| 0.126 | 0.004 | 0.126 | Retinoic acid receptor agonist | 0.031 0.009 CID_154699944 | ||
| 0.133 | 0.012 | 0.133 | Bile acid receptor antagonist | |||
| 0.123 | 0.004 | 0.123 | Retinoid X alpha receptor agonist | |||
| 0.209 | 0.09 | 0.715 | Angiogenesis stimulant | 0.715 0.004 CID_154699944 | CID_154699944 | |
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.157 | 0.043 | 0.265 | Alkylator | 0.265 0.015 CID_154699944 | CID_154699944 | |
| 0.129 | 0.016 | 0.129 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.162 | 0.049 | 0.162 | Neurotrophic factor | 0.14 0.069 CID_154699944 | ||
| 0.189 | 0.08 | 0.265 | Non-steroidal antiinflammatory agent | 0.265 0.037 CID_154699944 | CID_154699944 | |
| 0.112 | 0.004 | 0.112 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.124 | 0.016 | 0.124 | Lipase inhibitor | 0.117 0.019 CID_154699944 | ||
| 0.144 | 0.036 | 0.144 | Mucolytic | 0.123 0.051 CID_154699944 | ||
| 0.111 | 0.004 | 0.111 | Retinoid X receptor agonist | |||
| 0.179 | 0.072 | 0.179 | Lipocortins synthesis antagonist | 0.135 0.13 CID_154699944 | ||
| 0.152 | 0.046 | 0.424 | Monophenol monooxygenase inhibitor | 0.424 0.01 CID_154699944 | CID_154699944 | |
| 0.109 | 0.004 | 0.109 | Kainate receptor 3 antagonist | |||
| 0.202 | 0.097 | 0.202 | RNA-directed DNA polymerase inhibitor | 0.174 0.144 CID_154699944 | ||
| 0.15 | 0.046 | 0.15 | Heat shock protein 70 antagonist | 0.138 0.084 CID_154699944 | ||
| 0.108 | 0.006 | 0.108 | Exportin-1 inhibitor | |||
| 0.11 | 0.007 | 0.11 | Glutamate (mGluR6) antagonist | |||
| 0.111 | 0.008 | 0.111 | Leukotriene B4 antagonist | 0.105 0.009 CID_154699944 | ||
| 0.106 | 0.004 | 0.106 | Retinoic acid alpha receptor agonist | 0.044 0.02 CID_154699944 | ||
| 0.104 | 0.004 | 0.125 | Glucose-6-phosphate isomerase inhibitor | 0.125 0.003 CID_154699944 | CID_154699944 | |
| 0.102 | 0.004 | 0.102 | Membrane dipeptidase inhibitor | |||
| 0.164 | 0.072 | 0.164 | Neurotensin receptor agonist | |||
| 0.131 | 0.039 | 0.156 | Mediator release inhibitor | 0.156 0.026 CID_154699944 | CID_154699944 | |
| 0.114 | 0.023 | 0.114 | Keratolytic | |||
| 0.138 | 0.047 | 0.138 | Cystathionine beta-synthase inhibitor | |||
| 0.142 | 0.052 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.112 | 0.023 | 0.112 | Vanilloid agonist | 0.085 0.058 CID_154699944 | ||
| 0.131 | 0.042 | 0.184 | Xanthine oxidase inhibitor | 0.184 0.023 CID_154699944 | CID_154699944 | |
| 0.243 | 0.155 | 0.243 | Calcium channel activator | |||
| 0.108 | 0.02 | 0.108 | HIV-1 integrase (Strand Transfer) inhibitor | 0.087 0.028 CID_154699944 | ||
| 0.092 | 0.005 | 0.092 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.108 | 0.021 | 0.108 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.11 | 0.023 | 0.11 | Aminopeptidase I inhibitor | |||
| 0.115 | 0.031 | 0.236 | NADH dehydrogenase inhibitor | 0.236 0.008 CID_154699944 | CID_154699944 | |
| 0.148 | 0.064 | 0.148 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.095 | 0.013 | 0.095 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.104 | 0.024 | 0.104 | Leukotriene synthesis inhibitor | |||
| 0.114 | 0.035 | 0.127 | Thioredoxin inhibitor | 0.127 0.027 CID_154699944 | CID_154699944 | |
| 0.103 | 0.026 | 0.103 | CDC25A inhibitor | |||
| 0.121 | 0.044 | 0.121 | DOPA decarboxylase inhibitor | |||
| 0.079 | 0.003 | 0.079 | Retinoid X receptor antagonist | |||
| 0.104 | 0.028 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 CID_154699944 | CID_154699944 | |
| 0.147 | 0.072 | 0.147 | Thiol protease inhibitor | |||
| 0.123 | 0.049 | 0.245 | Expectorant | 0.245 0.013 CID_154699944 | CID_154699944 | |
| 0.079 | 0.007 | 0.079 | Prostaglandin agonist | |||
| 0.09 | 0.018 | 0.09 | Antimetabolite | 0.078 0.02 CID_154699944 | ||
| 0.092 | 0.021 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.072 | 0.004 | 0.072 | Glutamate (mGluR1) agonist | |||
| 0.069 | 0.003 | 0.069 | Retinoid X alpha receptor antagonist | |||
| 0.084 | 0.019 | 0.089 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.089 0.017 CID_154699944 | CID_154699944 | |
| 0.091 | 0.025 | 0.091 | Vanilloid 4 agonist | |||
| 0.129 | 0.065 | 0.129 | Cathepsin H inhibitor | |||
| 0.132 | 0.069 | 0.173 | Interleukin 4 antagonist | 0.173 0.033 CID_154699944 | CID_154699944 | |
| 0.169 | 0.108 | 0.169 | Anticonvulsant | |||
| 0.107 | 0.046 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.067 | 0.008 | 0.07 | Microtubule stabilization | 0.07 0.006 CID_154699944 | CID_154699944 | |
| 0.124 | 0.066 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.073 | 0.016 | 0.073 | Thromboxane synthase inhibitor | |||
| 0.059 | 0.002 | 0.059 | Retinoid X gamma receptor antagonist | 0.035 0.007 CID_154699944 | ||
| 0.098 | 0.041 | 0.179 | Transcription factor NF kappa B stimulant | 0.179 0.011 CID_154699944 | CID_154699944 | |
| 0.121 | 0.066 | 0.121 | Anesthetic local | |||
| 0.07 | 0.016 | 0.07 | Farnesyltransferase inhibitor | |||
| 0.069 | 0.015 | 0.069 | Leukotriene C antagonist | |||
| 0.065 | 0.012 | 0.065 | Glutamate (mGluR4) antagonist | |||
| 0.054 | 0.002 | 0.054 | Retinoid X beta receptor antagonist | |||
| 0.078 | 0.026 | 0.078 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.061 0.038 CID_154699944 | ||
| 0.106 | 0.054 | 0.343 | UDP-glucose 4-epimerase inhibitor | 0.343 0.008 CID_154699944 | CID_154699944 | |
| 0.096 | 0.045 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.023 CID_154699944 | CID_154699944 | |
| 0.09 | 0.038 | 0.14 | Interferon agonist | 0.14 0.012 CID_154699944 | CID_154699944 | |
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR group III) antagonist | |||
| 0.136 | 0.084 | 0.136 | Pregnane X receptor agonist | |||
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | |||
| 0.081 | 0.032 | 0.081 | Phospholipase D inhibitor | |||
| 0.093 | 0.044 | 0.093 | Inducible nitric-oxide synthase inhibitor | |||
| 0.066 | 0.018 | 0.106 | Glucose-6-phosphate translocase inhibitor | 0.106 0.005 CID_154699944 | CID_154699944 | |
| 0.053 | 0.006 | 0.053 | HMG CoA reductase inhibitor | 0.038 0.018 CID_154699944 | ||
| 0.051 | 0.004 | 0.051 | Retinoic acid receptor antagonist | 0.018 0.013 CID_154699944 | ||
| 0.056 | 0.009 | 0.056 | Glutamate (mGluR8) agonist | |||
| 0.051 | 0.004 | 0.051 | Retinoic acid beta receptor agonist | |||
| 0.076 | 0.029 | 0.076 | Prostaglandin EP2 antagonist | |||
| 0.057 | 0.011 | 0.057 | AMPA 4 receptor antagonist | |||
| 0.049 | 0.004 | 0.049 | Prostaglandin F2 alpha agonist | |||
| 0.088 | 0.044 | 0.088 | Estrogen-related receptor beta agonist | |||
| 0.053 | 0.01 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.097 | 0.055 | 0.097 | Alcohol dehydrogenase inhibitor | |||
| 0.139 | 0.097 | 0.146 | CF transmembrane conductance regulator agonist | 0.146 0.084 CID_154699944 | CID_154699944 | |
| 0.057 | 0.016 | 0.057 | Geranyltranstransferase inhibitor | |||
| 0.046 | 0.006 | 0.046 | Prostaglandin E2 agonist | |||
| 0.044 | 0.004 | 0.044 | Retinoic acid gamma receptor agonist | 0.022 0.016 CID_154699944 | ||
| 0.069 | 0.029 | 0.069 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.049 | 0.01 | 0.049 | Angiotensin AT2 receptor antagonist | |||
| 0.042 | 0.004 | 0.058 | Vanilloid 2 agonist | 0.058 0.002 CID_154699944 | CID_154699944 | |
| 0.042 | 0.004 | 0.042 | Retinoic acid alpha receptor antagonist | |||
| 0.069 | 0.031 | 0.069 | Ribonucleotide reductase inhibitor | |||
| 0.052 | 0.014 | 0.052 | Nicotinic acid receptor agonist | |||
| 0.039 | 0.003 | 0.039 | Neuraminidase (Influenza B) inhibitor | 0.026 0.006 CID_154699944 | ||
| 0.089 | 0.053 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.043 | 0.007 | 0.043 | Prostaglandin EP2 agonist | 0.023 0.016 CID_154699944 | ||
| 0.045 | 0.009 | 0.045 | ATP citrate lysase inhibitor | |||
| 0.064 | 0.028 | 0.134 | Protein 50S ribosomal subunit inhibitor | 0.134 0.008 CID_154699944 | CID_154699944 | |
| 0.058 | 0.023 | 0.058 | Adenosine deaminase inhibitor | 0.054 0.026 CID_154699944 | ||
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | |||
| 0.04 | 0.005 | 0.04 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.145 | 0.111 | 0.396 | Platelet adhesion inhibitor | 0.396 0.012 CID_154699944 | CID_154699944 | |
| 0.091 | 0.059 | 0.099 | Glutamate release inhibitor | 0.099 0.045 CID_154699944 | CID_154699944 | |
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | |||
| 0.06 | 0.027 | 0.097 | Alpha-mannosidase inhibitor | 0.097 0.007 CID_154699944 | CID_154699944 | |
| 0.174 | 0.142 | 0.348 | Spasmolytic | 0.348 0.053 CID_154699944 | CID_154699944 | |
| 0.038 | 0.006 | 0.038 | Prostaglandin EP4 agonist | |||
| 0.063 | 0.031 | 0.063 | Ryanodine receptor antagonist | |||
| 0.05 | 0.018 | 0.05 | Angiotensin AT1 receptor antagonist | |||
| 0.071 | 0.041 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.059 | 0.03 | 0.105 | Adenine nucleotide translocase inhibitor | 0.105 0.004 CID_154699944 | CID_154699944 | |
| 0.065 | 0.036 | 0.065 | Transcription factor AP-1 inhibitor | |||
| 0.086 | 0.058 | 0.086 | Epidermal growth factor antagonist | |||
| 0.054 | 0.026 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699944 | CID_154699944 | |
| 0.039 | 0.012 | 0.039 | Leukotriene B4 receptor 1 antagonist | |||
| 0.073 | 0.048 | 0.073 | Histidine decarboxylase inhibitor | |||
| 0.038 | 0.013 | 0.038 | Uridine phosphorylase inhibitor | 0.038 0.013 CID_154699944 | ||
| 0.039 | 0.013 | 0.039 | Prostaglandin D2 agonist | |||
| 0.045 | 0.02 | 0.045 | GABA uptake inhibitor | |||
| 0.105 | 0.08 | 0.105 | Adenylate cyclase inhibitor | |||
| 0.053 | 0.029 | 0.053 | CD45 antagonist | |||
| 0.05 | 0.026 | 0.05 | Adenylate cyclase 1 inhibitor | |||
| 0.057 | 0.033 | 0.057 | Dihydroorotate oxidase inhibitor | |||
| 0.145 | 0.121 | 0.145 | Psychostimulant | |||
| 0.183 | 0.159 | 0.183 | Transcription factor STAT3 inhibitor | |||
| 0.057 | 0.034 | 0.057 | Thromboxane antagonist | |||
| 0.106 | 0.083 | 0.106 | Caspase 3 inhibitor | |||
| 0.04 | 0.017 | 0.04 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.076 | 0.055 | 0.076 | Estrogen receptor alpha antagonist | |||
| 0.113 | 0.092 | 0.117 | Bone formation stimulant | 0.117 0.088 CID_154699944 | CID_154699944 | |
| 0.037 | 0.016 | 0.037 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.039 | 0.019 | 0.039 | Glutamate (mGluR8) antagonist | |||
| 0.035 | 0.015 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase VIII inhibitor | |||
| 0.025 | 0.005 | 0.025 | Carbonic anhydrase X inhibitor | |||
| 0.05 | 0.032 | 0.05 | HCV NS3/NS4A protease inhibitor | |||
| 0.037 | 0.019 | 0.037 | Angiotensin II receptor antagonist | |||
| 0.022 | 0.005 | 0.022 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.035 | 0.018 | 0.035 | Carboxypeptidase B inhibitor | |||
| 0.062 | 0.045 | 0.062 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 CID_154699944 | ||
| 0.021 | 0.004 | 0.021 | Retinoic acid receptor gamma antagonist | |||
| 0.101 | 0.085 | 0.118 | Acetylcholine release stimulant | 0.118 0.052 CID_154699944 | CID_154699944 | |
| 0.039 | 0.023 | 0.039 | Integrin alpha1beta1 antagonist | |||
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_154699944 | ||
| 0.071 | 0.056 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.051 | 0.036 | 0.051 | Thromboxane A2 antagonist | |||
| 0.018 | 0.004 | 0.018 | Calcineurin inhibitor | 0.011 0.009 CID_154699944 | ||
| 0.039 | 0.025 | 0.039 | 5-Alpha-reductase inhibitor | |||
| 0.019 | 0.005 | 0.019 | Retinoic acid beta receptor antagonist | |||
| 0.105 | 0.091 | 0.105 | Glutamate receptor antagonist | |||
| 0.048 | 0.034 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.09 | 0.076 | 0.123 | Phosphodiesterase 6D inhibitor | 0.123 0.022 CID_154699944 | CID_154699944 | |
| 0.024 | 0.011 | 0.024 | Angiotensin AT1A receptor antagonist | |||
| 0.06 | 0.047 | 0.06 | NMDA receptor agonist | |||
| 0.088 | 0.075 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.045 | 0.032 | 0.091 | Mannosidase inhibitor | 0.091 0.007 CID_154699944 | CID_154699944 | |
| 0.019 | 0.007 | 0.019 | Thromboxane A2 agonist | |||
| 0.045 | 0.033 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.064 0.01 CID_154699944 | CID_154699944 | |
| 0.031 | 0.019 | 0.031 | AMPA 1 receptor antagonist | |||
| 0.019 | 0.007 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 CID_154699944 | CID_154699944 | |
| 0.034 | 0.022 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.173 | 0.162 | 0.173 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.051 | 0.039 | 0.051 | Vanilloid 2 antagonist | |||
| 0.072 | 0.061 | 0.072 | GABA B receptor agonist | |||
| 0.153 | 0.142 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.058 | 0.047 | 0.058 | Purinergic P2X1 antagonist | |||
| 0.04 | 0.029 | 0.04 | Toll-Like receptor 2 agonist | 0.039 0.03 CID_154699944 | ||
| 0.164 | 0.153 | 0.304 | DNA damaging | 0.304 0.055 CID_154699944 | CID_154699944 | |
| 0.061 | 0.051 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.048 | 0.038 | 0.048 | Squalene epoxidase inhibitor | |||
| 0.041 | 0.031 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.059 | 0.049 | 0.059 | Prostaglandin F2 alpha antagonist | |||
| 0.029 | 0.021 | 0.029 | AMPA 3 receptor antagonist | |||
| 0.061 | 0.052 | 0.092 | Interferon inducer | 0.092 0.016 CID_154699944 | CID_154699944 | |
| 0.019 | 0.011 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.055 | 0.047 | 0.055 | Carbonic anhydrase stimulant | |||
| 0.055 | 0.048 | 0.071 | Lipocortins synthesis agonist | 0.071 0.02 CID_154699944 | CID_154699944 | |
| 0.021 | 0.014 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.022 | 0.015 | 0.022 | Leukotriene B4 receptor 2 antagonist | |||
| 0.012 | 0.007 | 0.012 | Thromboxane agonist | |||
| 0.087 | 0.083 | 0.087 | Gastric antisecretory | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.038 | 0.034 | 0.038 | VCAM-1 antagonist | |||
| 0.038 | 0.034 | 0.038 | VCAM antagonist | |||
| 0.064 | 0.061 | 0.064 | Cathepsin G inhibitor | |||
| 0.096 | 0.093 | 0.096 | Proteasome inhibitor | |||
| 0.046 | 0.043 | 0.046 | Beta 2 adrenoreceptor antagonist | |||
| 0.073 | 0.071 | 0.073 | ErbB-3 antagonist | |||
| 0.016 | 0.014 | 0.022 | Telomerase stimulant | 0.022 0.005 CID_154699944 | CID_154699944 | |
| 0.031 | 0.03 | 0.041 | Arginase inhibitor | 0.041 0.021 CID_154699944 | CID_154699944 | |
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.053 | 0.054 | 0.107 | Neuraminidase inhibitor | 0.107 0.013 CID_154699944 | CID_154699944 | |
| 0.019 | 0.025 | 0.023 | Vitamin D receptor antagonist | 0.023 0.013 CID_154699944 | CID_154699944 | |
| 0.051 | 0.059 | 0.367 | Selectin antagonist | 0.367 0.004 CID_154699944 | CID_154699944 | |
| 0.114 | 0.129 | 0.297 | NOS3 expression enhancer | 0.297 0.018 CID_154699944 | CID_154699944 | |
| 0.053 | 0.073 | 0.121 | Neuraminidase (influenza) inhibitor | 0.121 0.011 CID_154699944 | CID_154699944 | |
| 0.009 | 0.029 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_154699944 | CID_154699944 | |
| 0.004 | 0.026 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_154699944 | CID_154699944 | |
| 0.043 | 0.067 | 0.089 | Heparanase inhibitor | 0.089 0.005 CID_154699944 | CID_154699944 | |
| 0.063 | 0.09 | 0.138 | Cell adhesion molecule inhibitor | 0.138 0.018 CID_154699944 | CID_154699944 | |
| 0.013 | 0.05 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_154699944 | CID_154699944 | |
| 0.011 | 0.055 | 0.021 | Corticosteroid-like | 0.021 0.014 CID_154699944 | CID_154699944 | |
| 0.068 | 0.113 | 0.088 | Uric acid excretion stimulant | 0.088 0.068 CID_154699944 | CID_154699944 | |
| 0.135 | 0.183 | 0.171 | Cyclic AMP phosphodiesterase inhibitor | 0.171 0.12 CID_154699944 | CID_154699944 | |
| 0.017 | 0.071 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 CID_154699944 | CID_154699944 | |
| 0.034 | 0.099 | 0.053 | Cytokine production stimulant | 0.053 0.023 CID_154699944 | CID_154699944 | |
| 0.011 | 0.081 | 0.057 | Sodium/glucose cotransporter 2 inhibitor | 0.057 0.005 CID_154699944 | CID_154699944 | |
| 0.024 | 0.099 | 0.047 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 CID_154699944 | CID_154699944 | |
| 0.052 | 0.138 | 0.249 | Topoisomerase I inhibitor | 0.249 0.017 CID_154699944 | CID_154699944 | |
| 0.012 | 0.102 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 CID_154699944 | CID_154699944 | |
| 0.104 | 0.195 | 0.16 | P-glycoprotein inhibitor | 0.16 0.103 CID_154699944 | CID_154699944 | |
| 0.056 | 0.155 | 0.198 | Topoisomerase II inhibitor | 0.198 0.034 CID_154699944 | CID_154699944 | |
| 0.156 | 0.258 | 0.549 | Alpha-glucosidase inhibitor | 0.549 0.066 CID_154699944 | CID_154699944 | |
| 0.037 | 0.148 | 0.113 | Topoisomerase II alpha inhibitor | 0.113 0.032 CID_154699944 | CID_154699944 | |
| 0.091 | 0.203 | 0.324 | Hemostatic | 0.324 0.014 CID_154699944 | CID_154699944 | |
| 0.027 | 0.144 | 0.068 | Nitric oxide donor | 0.068 0.035 CID_154699944 | CID_154699944 | |
| 0.083 | 0.204 | 0.135 | Hexokinase inhibitor | 0.135 0.097 CID_154699944 | CID_154699944 | |
| 0.016 | 0.16 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_154699944 | CID_154699944 | |
| 0.127 | 0.275 | 0.316 | Angiogenesis inhibitor | 0.316 0.085 CID_154699944 | CID_154699944 | |
| 0.045 | 0.237 | 0.161 | Beta glucuronidase inhibitor | 0.161 0.021 CID_154699944 | CID_154699944 | |
| 0.058 | 0.258 | 0.209 | Anticoagulant | 0.209 0.05 CID_154699944 | CID_154699944 | |
| 0.008 | 0.218 | 0.048 | Protein 30S ribosomal subunit inhibitor | 0.048 0.008 CID_154699944 | CID_154699944 | |
| 0.04 | 0.269 | 0.162 | AMP-activated protein kinase stimulant | 0.162 0.021 CID_154699944 | CID_154699944 | |
| 0.016 | 0.259 | 0.07 | Antibiotic Aminoglycoside-like | 0.07 0.006 CID_154699944 | CID_154699944 | |
| 0.059 | 0.374 | 0.128 | DNA repair enzyme inhibitor | 0.128 0.058 CID_154699944 | CID_154699944 | |
| 0.017 | 0.723 | 0.401 | Tumour necrosis factor alpha release inhibitor | 0.401 0.027 CID_154699944 | CID_154699944 | |
| 0.062 | 0.778 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.023 CID_154699944 | CID_154699944 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |